KIYATEC

KIYATEC

KIYATEC

Leveraging advanced (3D, perfused, multi-tissue) cell culture to better predict human response to drugs and biomaterials through services & 3DKUBE products.
Founded
2005
Raised
$3.2M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$3,000,000
Venture capital (Series B) - 2019
LabCorp VentureSouth
$180,000
Venture capital - 2014
Team Size
10+
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when KIYATEC makes some noise.